Table of Contents
1 Introduction
1.1 Market Definition
2 Market Overview
2.1 Introduction
2.2 Market Dynamics
2.2.1 Drivers
2.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
2.2.1.2 Decreasing Sequencing Costs
2.2.1.3 Growing Application Areas of Genomics
2.2.1.4 Entry of New Players and Start-Ups in the Genomics Market
2.2.2 Restraints
2.2.2.1 High Cost of Genomic Equipment
2.2.3 Opportunities
2.2.3.1 Use of Genomics in Specialized/Personalized Medicine
2.2.4 Challenges
2.2.4.1 Dearth of Trained Professionals
2.2.4.2 Secure Storage of Large Volumes of Sequenced Data
3 Company Evaluation Quadrant
3.1 Visionary Leaders
3.2 Innovators
3.3 Dynamic Differentiators
3.4 Emerging Companies
Figure 1 Genomics Market (Global) Company Evaluation Quadrant
3.5 Strength of Product Portfolio (25 Companies)
3.6 Business Strategy Excellence (25 Companies)
4 Company Evaluation Quadrant – Startups
4.1 Progressive Companies
4.2 Dynamic Companies
4.3 Responsive Companies
4.4 Starting Blocks
Figure 2 Genomics Market (Global) Company Evaluation Quadrant -Startups
5 Competitive Landscape
5.1 Overview
Figure 3 Genomics Market Share Analysis, By Key Player, 2018
5.1.1 Thermo Fisher Scientific
5.1.2 Illumina
5.1.3 QIAGEN
5.1.4 Others
5.2 Competitive Scenario
5.2.1 Product Launches and Approvals
Table 1 Product Launches and Approvals
5.2.2 Expansions
Table 2 Expansions
5.2.3 Agreements and Collaborations
Table 3 Agreements and Collaborations
5.2.4 Acquisitions
Table 4 Acquisitions
6 Company Profiles
6.1 Illumina, Inc.
6.1.1 Business Overview*
Figure 4 Illumina, Inc.: Company Snapshot (2018)
6.1.2 Products Offered*
6.1.3 Services Offered*
6.1.4 Recent Developments*
6.1.5 MnM View*
(*Above sections are present for all of below companies)
6.2 Thermo Fisher Scientific
Figure 5 Thermo Fisher Scientific, Inc.: Company Snapshot (2017)
6.3 QIAGEN
Figure 6 QIAGEN N.V.: Company Snapshot (2017)
6.4 Eurofins Scientific
Figure 7 Eurofins Scientific: Company Snapshot (2017)
6.5 Agilent Technologies
Figure 8 Agilent Technologies: Company Snapshot (2017)
6.6 Oxford Nanopore Technologies
6.7 F. Hoffmann-La Roche
Figure 9 Roche Holding AG: Company Snapshot (2017)
6.8 Bio-Rad Laboratories
Figure 10 Bio-Rad Laboratories, Inc.: Company Snapshot (2017)
6.9 BGI
6.10 Danaher Corporation
Figure 11 Danaher Corporation: Company Snapshot (2017)
6.11 GE Healthcare
Figure 12 General Electrical Company: Company Snapshot (2017)
6.12 Eppendorf
Figure 13 Eppendorf AG: Company Snapshot (2017)
7 Appendix
7.1 Methodology
This report identifies and benchmarks the best Genomics vendors such as Thermo Fisher Scientific, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US) and Eurofins Scientific (Germany), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the genomics ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. Best Genomics vendors are rated and positioned on 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies. This report also identifies and benchmarks the top genomics start-ups, positioned on a 2x2 matrix, and identified as Progressive Companies, Starting Blocks, Dynamic Companies, and Responsive Companies.
SAMPLES: